Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib.

Janet E Pope Yvonne C LeeJeffrey R CurtisDaojun MoLi XieChristina L DicksonDouglas E SchlichtingAnabela CardosoLee S SimonPeter C Taylor

Published in: ACR open rheumatology (2021)

Pain reduction was observed and was similar between opioid users and nonusers with baricitinib 2 mg and 4 mg but not adalimumab in this post hoc analysis.

Keyphrases

chronic pain
pain management
rheumatoid arthritis patients
disease activity
rheumatoid arthritis
neuropathic pain
spinal cord
ulcerative colitis